---
schema_version: "secwatch.filing_event.v1"
accession: "0000711404-24-000016"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:33:20.630499+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cooper Q1 revenue record $931.6M (+9% YoY); non-GAAP EPS $0.85 (+18%); FY24 guidance raised

## Summary
- Revenue of $931.6M, up 9% YoY; CooperVision $621.5M (+7%), CooperSurgical $310.1M (+12%).
- GAAP EPS $0.41 (down 5% YoY); non-GAAP EPS $0.85 (up 18% YoY).
- Gross margin improved to 67% (GAAP and non-GAAP) from 65%/66% last year.
- FY2024 guidance raised: revenue $3,847-$3,897M, non-GAAP EPS $3.50-$3.58.
- 4-for-1 stock split effective Feb 20, 2024; free cash flow $4.6M; net debt $2.6B.

## SEC filing metadata
- accession: 0000711404-24-000016
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000071140424000016/0000711404-24-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000071140424000016/coo-20240229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000711404-24-000016
- JSON: https://secwatch.observer/filing/0000711404-24-000016.json
- Plain text: https://secwatch.observer/filing/0000711404-24-000016.txt

## Key facts
- Earnings Releases
  COOPER COMPANIES, INC. reported its fiscal first quarter ended January 31, 2024 results: revenue $931.6 million, EPS $0.41. Guidance raised.
  - Period: its fiscal first quarter ended January 31, 2024
  - Revenue: $931.6 million
  - EPS: $0.41
  - Guidance: raised
  - Result: reported results
  source text: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. • Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million. • GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5%
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000071140424000016/0000711404-24-000016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.